Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CGP 35348 is a selective antagonist of GABAB receptor (EC50 = 34 μM). CGP 35348 can be used in studies of neuromuscular coordination and spatial learning after neonatal brain damage in albino mice.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 44.00 | |
2 mg | In stock | $ 64.00 | |
5 mg | In stock | $ 98.00 | |
10 mg | In stock | $ 172.00 | |
25 mg | In stock | $ 372.00 | |
50 mg | In stock | $ 597.00 | |
100 mg | In stock | $ 852.00 | |
500 mg | In stock | $ 1,730.00 |
Description | CGP 35348 is a selective antagonist of GABAB receptor (EC50 = 34 μM). CGP 35348 can be used in studies of neuromuscular coordination and spatial learning after neonatal brain damage in albino mice. |
In vivo | In male Wistar rats, CGP 35348(100, 300, and 900 mg/kg) produced an increase in the duration of non-REM sleep and rapid eye movement (REM) sleep and reduced strongly spike-wave discharges[2]. |
Molecular Weight | 225.22 |
Formula | C8H20NO4P |
CAS No. | 123690-79-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: < 2.25 mg/mL (10 mM, insoluble or slightly soluble)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CGP 35348 123690-79-9 Membrane transporter/Ion channel Neuroscience GABA Receptor spatial learning neuromuscular neonatal damage brain penetrant Gamma-aminobutyric acid Receptor centrally GABAB Inhibitor CGP35348 γ-Aminobutyric acid Receptor CGP-35348 inhibit active inhibitor